Goldman Sachs Adjusts Price Target on Citigroup to $77 From $81, Keeps Buy Rating
Daiwa Securities Adjusts Price Target on Citigroup to $89 From $90, Keeps Buy Rating
JPMorgan Adjusts Price Target on Citigroup to $75.50 From $71.50, Keeps Neutral Rating
Barclays Maintains Citigroup(C.US) With Buy Rating, Maintains Target Price $95
Citigroup: Raised the Target Price for MAOYAN ENT to HKD 9.2, rating "Buy".
Citigroup released a research report stating that it has raised the Target Price for MAOYAN ENT (01896) by 2.2%, from 9 HKD to 9.2 HKD, and included it in the top picks of the movie Industry, with a rating of "Buy." Additionally, the company's revenue forecast for 2025 to 2026 has been adjusted upward by 2% to 3%; adjusted net profit has been increased by 5% to 9%. The bank indicated that the company's worst times may be behind it. As the largest movie ticketing platform, it is expected to benefit from better movie supply this year, and the films it is releasing are still abundant. The next catalyst will be the Lunar New Year holiday release period. The bank predicts that the total box office in mainland China will reach 50 billion RMB in 2025, and
Express News | Citigroup : Truist Securities Initiates Coverage With Buy Rating; Price Target $85
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
Buy n Die Together❤ :
103575541 :
104088143 : What happened?